Secondary Insurer (Excess)

A secondary insurer, also known as an excess insurer, is an insurance company that provides coverage for losses that exceed the limits of the primary insurance policy. In other words, the secondary insurer pays out claims only after the primary insurance policy has been exhausted.

Here are some key features of a secondary insurer:

• Provides coverage for losses that exceed the limits of the primary insurance policy.

• Pays out claims only after the primary insurance policy has been exhausted.

• The amount of coverage provided by the secondary insurer is typically specified in the insurance contract.

• The secondary insurer may have different coverage terms and conditions than the primary insurer, such as different deductibles, limits, and exclusions.

• The cost of the secondary insurance policy is generally lower than that of the primary insurance policy, since it provides coverage only in excess of the primary policy.

For example, let's say a business has a primary liability insurance policy with a limit of $1 million and a secondary liability insurance policy with a limit of $2 million. If the business is sued for damages in excess of $1 million, the primary insurer will pay out up to its limit of $1 million, and the excess amount will be covered by the secondary insurer up to its limit of $2 million.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.